SFM
OMGA

Signet Financial Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Signet Financial Management’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000
Closed -$11K – 1403
2021
Q4 		$11K Buy
+1,000
New +$19K ﹤0.01% 1037

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Signet Financial Management's OMGA Position: Q1 2022 in Review

Signet Financial Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2022, closing a stake of 1,000 shares — an estimated $11K sold.

Signet Financial Management first reported a position in OMGA in Q4 2021 and held it in 1 quarter. The position peaked at $11K in Q4 2021. 52 funds tracked by Wall St. Rank hold OMGA as of Q1 2022.

  • Signet Financial Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Signet Financial Management sold 1,000 Omega Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $11K.
  • Signet Financial Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Signet Financial Management's Omega Therapeutics, Inc. Common Stock position peaked at $11K in Q4 2021.
  • 52 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.